Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PEB.NZ
SELLGet insider-trade alertsPacific Edge Limited · Healthcare · New Zealand · $210M · Avg Vol: $310K/d
29
StockRankQ
22
V
21
M
75
P/E (TTM)
—
ROE
-194.7%
D/E
0.1x
Dividend %
—
COMPANY DESCRIPTION
Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | 6.5M | 11.1M | 13.5M | 12.3M | — | 24.0% |
| EPS | — | -0.02 | -0.02 | -0.02 | -0.02 | — |
| Shares | — | 810.1M | 810.4M | 811.3M | 811.9M | +0.2% |
| Debt | — | 1.1M | 0.7M | 2.3M | 1.6M | 14.7% |
| Equity | — | 61.1M | 46.7M | 30.8M | 14.7M | -37.8% |
| Op CF | — | — | — | — | — | — |
| Inv CF | — | -29.4M | 12.7M | 12.5M | 3.8M | — |
| Fin CF | — | 56.8M | -0.7M | -0.6M | -0.9M | — |
Loading...
PRICE (1Y)+11.1%
SMA 50SMA 200
Close
$0.1692
RSI (14)
50.0
52W High
$0.1918
From 52W High
0.9%
SCORE BREAKDOWN
Quality
22
ROIC (ROA)
-83.2%*7.4
ROE
-194.7%3.6
GP/Assets
3.7%16.6
Op. Margin
-274.3%12.5
FCF/Assets
-51.7%4.2
Piotroski
238.6
Int. Cover
—N/A
D/E Ratio
0.12x63.4
Current Ratio
2.02x38.1
Value
21
P/E (TTM)
—N/A
EV/EBITDA
-8.5x25.0
P/FCF
—N/A
P/B
30.0x3.6
P/S
28.6x12.7
Div Yield
—N/A
Momentum
75
52W High %
88%83.1
RS 6M
81%96.3
SMA 50/200
1.22x90.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+70%62.7
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$210M
P/E (Forward)
-24.9x
Gross Margin
10.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PEB.NZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PEB.NZ | Pacific Edge Limited(you) | $210M | 29 | SELL |
| OCA.NZ | Oceania Healthcare Limited | $304M | 37 | HOLD |
| SUM.NZ | Summerset Group Holdings Limited | $1.2B | 28 | SELL |
| ARX.AX | Aroa Biosurgery Limited | $141M | 59 | HOLD |
| RYM.NZ | Ryman Healthcare Limited | $1.3B | 25 | SELL |
| AFT.NZ | AFT Pharmaceuticals Limited | $218M | 78 | BUY |
| GXH.NZ | Green Cross Health Limited | $159M | 99 | STRONG BUY |
| RAD.NZ | Radius Residential Care Limited | $62M | 96 | STRONG BUY |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $12.8B | 83 | STRONG BUY |
Peer medians: ROE 11.0% · P/E 20.1x · Gross margin 34.0%